News

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...
The black concrete walls outside Saskatoon’s only safe consumption site show the wake left by the city’s drug crisis.
In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the FDA, according to an exclusive report from The Wall Street Journal ...
Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...
Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...
Discover the 5 most effective food allergy testing methods for children, from elimination diets to oral food challenges, ...
Artificial intelligence (AI) is taking over the world. The U.S. Food and Drug Administration (FDA) recently announced it would phase out animal testing in drug development in favor of other methods, ...
The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
The Drug Allergy History Tool, which relies on patient symptom reporting, has strong reliability when compared with EHR drug allergy information.
FDA clears Nurix Therapeutics, Inc.'s GS-6791 for inflammatory disorders; Nurix earns $5M milestone from Gilead. Click for my ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...